A

Amgen

Makes biotech medicines for serious illnesses

Engineer 1 (Calibration)

Full-TimeUpdated on 10/24/2026
No salary listed
Entry, Junior
Bachelor's, Master's, Associate's
Singapore
In PersonOn-site at Singapore Manufacturing - Tuas.
General Maintenance & RepairEquipment Maintenance

About the job

Requirements
  • A master’s degree, or a bachelor’s degree and 2 years of directly related experience, or an associate’s degree and/or 4 years of directly related experience, or a high school diploma/GED and 6 years of directly related experience.
  • Experience leading collaborators’ expectations.
  • Strong technical knowledge of utilities, mechanical maintenance, maintenance execution, and equipment troubleshooting in a GMP manufacturing environment.
  • Ability to provide technical oversight, influence maintenance execution, and guide technicians and contractors without direct people-management accountability.
  • Strong communication and interpersonal skills for working with Manufacturing, Maintenance, Engineering, Quality, EHS, Planning and Scheduling, System Owners, contractors, and vendors.
  • Strong analytical and science-based problem-solving skills, including troubleshooting, Root Cause Analysis, CAPA implementation, and continuous improvement.
  • Proven experience working in a GMP environment with awareness of safety, compliance, documentation, and maintenance quality requirements.
  • Experience managing contractors, vendors, and third-party service providers for routine, non-routine, and improvement maintenance activities.
  • Ability to communicate complex technical ideas clearly and practically to non-engineering stakeholders.
  • Medical requirements associated with the job scope must be fulfilled.
Responsibilities
  • Provide technical support and leadership within assigned systems, equipment, and workstreams, including maintenance execution, breakdown troubleshooting, work-quality verification, technician coaching, and safe, compliant, right-first-time maintenance practices in GMP manufacturing.
  • Provide practical technical leadership for electrical, calibration, instrumentation, analytical equipment, utilities, and maintenance execution, focusing on equipment reliability, troubleshooting, field decision-making, and issue resolution.
  • Partner with Manufacturing, Maintenance, Engineering, Quality, EHS, Planning and Scheduling, System Owners, contractors, and vendors to support production, improve preventive maintenance, resolve deviations and non-conformances, and drive continuous improvement from field execution.
  • Support implementation, maintenance, and continuous improvement of the site calibration strategy, serving as technical point of contact for assigned systems, equipment, or program elements.
  • Serve as technical contact for calibration, instrumentation, and analytical-equipment activities and, when designated, as primary technical contact for defined systems or workstreams.
  • Develop, review, and approve calibration data sheets for assigned projects, systems, and equipment in accordance with delegated authority and approved CMMS and calibration-program requirements.
  • Assess metrology systems, standards, instruments, and equipment to ensure measurement accuracy and precision in line with the corporate calibration program.
  • Participate in supplier audits to incorporate suppliers as approved calibration suppliers within the Calibration Program.
  • Apply equipment and process-equipment knowledge to solve equipment failures or malfunctions and develop technical assessments.
  • Coordinate activities and provide technical guidance, coaching, and work-quality review to technicians, engineers, and contractors, without direct people-management accountability.
  • Execute installation, operation, and performance qualification.
  • Lead routine or clearly defined non-conformance and deviation investigations, including technical inputs for CAPA and change control; support or lead more complex investigations, CAPA actions, and change controls as assigned.
  • Apply project-management skills and engineering principles and practices across a broad variety of assignments in related fields.
  • Manage 230V/400V small power distribution boards, UPS systems, gensets, and Ex-rated equipment.
  • Lead and support electrical switchgear maintenance, troubleshooting, and root-cause-analysis documentation.
  • Support predictive maintenance and small capital-expenditure projects.
  • Ensure regulatory compliance, including NEA, EnMS, GHG, and EUR requirements, and perform energy reporting.
  • Identify cost, reliability, and resource-optimization opportunities through shopfloor engagement, maintenance-execution review, and stakeholder discussions; engage the global network to share and adopt relevant best practices without broader network accountability.
  • Build technician capability through practical technical guidance, hands-on coaching during field execution, and modeling strong safety, GMP, and maintenance practices.
  • Partner with maintenance managers as a member of the GMP F&E extended leadership team to improve instrumentation support.
  • Triage and resolve electrical or instrumentation process deviations and non-conformances.
  • Provide visible shopfloor technical support during maintenance execution, equipment breakdowns, troubleshooting, start-up, shutdown, and post-maintenance verification.
  • Work with technicians and contractors at equipment to diagnose issues, verify maintenance quality, coach correct work practices, and reinforce GMP and safety expectations.
  • Review field work execution to identify technical gaps, recurring equipment issues, job-plan improvements, and training needs.
  • Support urgent production and utility issues with practical, science-based troubleshooting and timely escalation.
  • Develop and maintain field-based technical training and qualification roadmaps for maintenance personnel in calibration and electrical disciplines, using equipment issues, job observations, troubleshooting cases, and hands-on coaching.
  • Capture and share field knowledge from calibration, instrumentation, and electrical maintenance, including troubleshooting guides, lessons learned, best practices, technical standards, and training materials.
  • Assess technician technical proficiency through field observations, practical assessments, and coaching, identifying gaps and development opportunities.
  • Provide field-based technical oversight of maintenance service providers and contractors, ensuring work quality, compliance with engineering standards, safe GMP practices, and knowledge transfer to site personnel.
  • Provide technical input to technician qualification and contractor-performance assessments while the accountable manager or contract owner retains formal performance accountability.
  • Provide technical expertise to support the established calibration program and, when designated, serve as subject-matter expert for assigned systems, equipment, or defined program elements.
Desired Qualifications
  • Experience with CMMS work-order management, preventive maintenance, job-plan improvement, maintenance procedures, and schedule coordination.
  • Experience developing or supporting technical training frameworks, qualification programs, technician competency assessments, knowledge repositories, or contractor technical-governance programs.
  • Knowledge of digital and analytical tools such as Excel, Power BI, Tableau, Smartsheet, Spotfire, or similar tools.
  • Knowledge of regulatory requirements for pharmaceutical instrumentation applications and analytical equipment, including USP 857, USP 645, and ISO 17025.

About the company

Amgen develops and makes biologic medicines, which are drugs built from proteins and antibodies grown in living cells, for serious conditions such as heart disease, cancer, and bone loss. Its anemia drug Epogen, approved in 1989, became one of the biotechnology industry's first blockbuster medicines. Amgen grows these drugs in large tanks called bioreactors, and its products include the cholesterol drug Repatha, the bone-building drug Evenity, and the severe asthma drug Tezspire. It earns money by selling these medicines, mostly through large drug wholesalers that supply hospitals and pharmacies. Amgen was founded in 1980 and is based in Thousand Oaks, California.

Company Size

10,001+

Company Stage

IPO

Headquarters

Thousand Oaks, California

Founded

1980

Get referred to Amgen

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Growth is broad-based: 22 products grew at least 10%, lifting June 2026 quarter revenue 10% to $10.1 billion.
  • Stock grants gained value: Amgen shares rose 27% from January to October 9, 2026, versus 10% for rival Eli Lilly.
  • Many U.S. roles are remote: 145 of Amgen's 615 U.S. job openings in October 2026 were fully remote.

What critics are saying

  • Its 2025 best seller is shrinking: cheaper copies cut bone drug Prolia's sales 32% in the June 2026 quarter.
  • MariTide, Amgen's obesity bet, faces a giant: Lilly's Mounjaro and Zepbound outsold all of Amgen in the June 2026 quarter.
  • Most tech openings are in India: 156 of Amgen's 210 information systems jobs in October 2026 were in Hyderabad.

What makes Amgen unique

  • It copies rivals' blockbusters too: Pavblu, its version of Regeneron's eye drug Eylea, sold $700 million in 2025.
  • Amgen hunts drug targets in a nation's DNA: its Icelandic unit deCODE has genetic data on two-thirds of Iceland's adults.
  • Amgen opened a U.S. cancer-drug class: Blincyto, approved in 2014, was the first to tether immune cells to cancer.

Help us improve and share your feedback! Did you find this helpful?

Benefits

  • Professional Development Budget
  • Conference Attendance Budget

Company News

Yahoo Finance
Oct 24th, 2026
Amgen vs Johnson & Johnson: cheaper Amgen edges J&J's $94.2B revenue giant on valuation

A Motley Fool comparison of Amgen and Johnson & Johnson (J&J) favours Amgen, mainly on price. Amgen's forward price-to-earnings ratio is 19.4x, against 24.1x for J&J. In 2025, Amgen's revenue rose about 10% to $36.7 billion, with net income of $7.7 billion. J&J's revenue grew 6% to $94.2 billion, with net income of $26.8 billion and free cash flow of $19.7 billion. Amgen carries far more debt: its debt-to-equity ratio is nearly 6.3x, against about 0.6x for J&J. Three wholesalers account for 77% of its gross revenues. Amgen also struck a deal with the US government that exempts it from pharmaceutical tariffs for three years in return for price cuts on two drugs. J&J expects revenue of $101 billion this fiscal year, and Amgen expects about $37.8 billion.

Yahoo Finance
Oct 22nd, 2026
Eli Lilly vs Amgen: $65.2B revenue and 45% growth against a cheaper stock for 2026

Eli Lilly is growing far faster than Amgen, but investors pay a steep premium for it. The article's author favours Lilly for long-term investors in 2026. Lilly's FY 2025 revenue rose 45% to about $65.2 billion, with net income of $20.6 billion and a 32% net margin. Amgen's revenue grew about 10% to $36.7 billion, with net income of $7.7 billion and a 21% margin. Lilly trades at a forward P/E of 38.3x against Amgen's 19.4x. Its debt-to-equity ratio is about 1.6x, compared with nearly 6.3x for Amgen. Lilly's growth rests on its GLP-1 drugs Zepbound and Mounjaro. The article projects 2026 revenue of $88.7 billion, against about $37.8 billion for Amgen.

Yahoo Finance
Oct 21st, 2026
Amgen's focus shifts to six growth drivers and MariTide as rare disease sales hit $1.6B

Amgen now frames its story around six key growth drivers, which grew 26% from a year earlier in fiscal Q2 2026 and made up nearly 70% of product sales. Rare disease, once reported on its own, is one of the six. The rare disease portfolio grew 21% to $1.6 billion, about 16% of quarterly revenue. Total revenue rose 9.5%, and management raised its 2026 revenue guidance to between $38.2 billion and $39.4 billion. Management also highlighted MariTide, an obesity drug in Phase III trials. Amgen wants it to be the first monthly or less frequent obesity therapy and is already scaling up manufacturing. One risk sits in rare disease. On September 1, 2026, Britain's medicines regulator suspended Tavneos for new patients, citing an unreliable main study. The drug made $119 million in fiscal Q1 2026. Amgen's next report is expected around November 3, 2026.

Yahoo Finance
Oct 20th, 2026
Johnson & Johnson and Amgen beat the market in 2026, but can the dividend stocks keep going?

Johnson & Johnson and Amgen, two dividend stocks that have beaten the broader market this year, could suit investors bracing for a possible crash. J&J's latest quarter beat expectations, and it slightly raised its 2026 guidance. But its medtech unit is struggling, as demand for the Impella heart pump has fallen amid safety questions and a US Class 1 recall. Long-term, it has new drugs, a robotic surgery system approved in the US, and a proposed $5.5 billion talc settlement. It is a Dividend King with 64 straight years of payout increases. Amgen's second-quarter revenue rose 10% to $10.1 billion, despite pressure on Tavneos and falling denosumab sales. It has raised payouts 152% over a decade and offers a 2.3% forward yield, against 1.1% for the S&P 500.

Yahoo Finance
Oct 17th, 2026
Amgen raises 2026 revenue forecast to $38.8B as shares gain 15.2%

Amgen raised its fiscal 2026 revenue forecast on August 4 to $38.8 billion at the midpoint, up 2.6% from $37.8 billion. Adjusted earnings per share guidance rose to $22.90 from $22.40. Six key growth drugs grew 26% from a year earlier and made up nearly 70% of product sales in the June quarter. Repatha sales rose 37% to $953 million, offsetting a 33% drop in Prolia and XGEVA sales as biosimilar copies launched. Total revenue rose 10%. The stock has gained 15.2% since the release, against 1.9% for the S&P 500. It closed at $434.03 on October 15, above both its 50-day and 200-day averages. Reaching the midpoint requires $20.1 billion in the second half. Amgen's next report is expected around November 3.